“…Defective PKC activation with aging has also been reported by several authors in human monocytes [18,19] and in human T lymphocytes [20,21], and ϳ50% of elderly subjects has significant reduction in PKC activity in B cells [22]. Agerelated impairment of the translocation of PKC is likely to underlie downstream defects in the activation of immune responses in vitro, as diminished generation of cytotoxic effectors, lower production of some cytokines, and reduced proliferative responses, and in vivo, as diminished response to vaccination and increased susceptibility to infections.…”